Status:
RECRUITING
Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Epilepsy
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two groups of patients will...
Detailed Description
The study will be proposed to patients with uncontrolled epilepsy (n=74) aged 18 to 40. The investigators will evaluate 3 months after the last therapeutic patient session, the impact of the epilepsy...
Eligibility Criteria
Inclusion
- Patient between 18 and 60 years old
- Patient with poorly controlled epilepsy (persistence of seizures evolving for more than a year despite proper treatment) or patient seizure-free for over a year but for whom therapeutic patient education (TPE) would be beneficial according to the investigator..
- Patient agreeing to participate in a therapeutic education program (TPE)
Exclusion
- Epileptic patient who has already benefited from a TPE epilepsy program
- Patients with major cognitive impairment
- Patient under guardianship or legal protection (safeguard of justice)
- Pregnant or breast-feeding women
- Failure to obtain written informed consent after a reflection period
- Patient who for geographical, social or psychological reasons could not participate in the research
- Any situation that, in the opinion of the investigator, could present risks to the patient and to the research
- Participation in another therapeutic research
- Subjects not covered by public health insurance
Key Trial Info
Start Date :
April 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 16 2028
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT06202196
Start Date
April 16 2024
End Date
April 16 2028
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Gui de Chauliac
Montpellier, France